We’re excited you’re going to join us for the Webinar: Put Your Money Where Your Mind Is: The Psychedelic Investment Landscape on May 6 at 13:00 EST. We’re looking forward to connecting with each other and hearing what Bruce Linton, Jayashree Mitra, and Alex Speiser have to say about investing in psychedelics. The webinar will be moderated by Hayim Raclaw, PsyTech managing director. Add the webinar to your calendar below and until then, stay healthy.
By Shira Jacobson Ketamine therapy is rapidly emerging as an effective and viable option for patients suffering from depression, anxiety, PTSD, end-of-life distress, chronic pain
By Uri Shine The potential for psychedelics to treat mental health is no longer a secret held by counterculturalists and underground therapists. Research from top
By Tessa Eskin Microdosing has officially hit the mainstream. The trend spread like wildfire across Silicon Valley, with tech professionals integrating minute doses of psychedelics
Eastra Health is the world’s first female-focused biotech delivering psychedelic derived medicines addressing PMS, menopause, and sexual enhancement. At PsyTech’s pitch event at our recent
This year’s pitch event wound up in a dramatic finish! Following pitches from four businesses, the judges selected Reagenics as the winner. While maintaining his
By Tessa Eskin Ibogaine recently made headlines with the commencement of Phase I/IIa trial testing treatment for opioid addiction at MAC Clinical Research. Opioid use
